Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid FES Exercise, NIV, and Buspirone in High-level Spinal Cord Injury
NCT04458324Phase 2Active, not recruiting
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Dec 2020
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in spinal cord injury (SCI), sponsored by Spaulding Rehabilitation Hospital. Started Dec 2020; status: active, not recruiting.
02
Drugs
buspirone
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT04458324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458324.